Jeffrey R. Baxter
Overview
Jeffrey R. Baxter received an average of $2M in total compensation, including $562K in salary, at VBI Vaccines from 2017 to 2023.
2023VBI VaccinesPresident, Chief Executive Officer
2022VBI VaccinesPresident, Chief Executive Officer
2021VBI VaccinesPresident, Chief Executive Officer
2020VBI VaccinesPresident and Chief Executive Officer
2019VBI VaccinesPresident and Chief Executive Officer
2018VBI VaccinesPresident and Chief Executive Officer
2017VBI VaccinesPresident and Chief Executive Officer
Source: SEC filings on April 29, 2024, May 1, 2023, April 29, 2022, April 26, 2021, April 28, 2020, and April 29, 2019.
Related executives
We found two more executives who work or worked at VBI Vaccines.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019